Search Videos and More
News
Dana-Farber Cancer Institute Faculty Among World's Most Highly Cited Researchers
Dana-Farber Cancer Institute is proud to announce that 42 of its researchers have been named to the Highly Cited Researchers list of 2024, released today by the Institute for Scientific Information at Clarivate.
News
First Clinical Trial of “Memory Like” Natural Killer Cells in Ovarian Cancer Opens at Dana-Farber
Investigators at Dana-Farber Cancer Institute are opening a new clinical trial to evaluate a novel type of immune cellular therapy in patients with recurrent, platinum resistant ovarian cancer.
News
Dana-Farber Research News 11.15.2024
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from October 16 through October 31.
News
Building in Access from the Start: Five Efforts by the Centers for Early Detection and Interception
Dana-Farber’s Centers for Early Detection and Interception, founded in 2023, aim to detect cancer early, when there is a greater chance of treating and curing that cancer.
News
Dana-Farber Researchers ‘Hijack’ Gut Bacteria to Design Novel Form of Cancer Immunotherapy
Tumors are experts at dodging the immune system. This evasion not only helps to ensure their survival, but also has important implications for treatment.
News
Study of Inherited Prostate Cancer Genetics in Africa Highlights Importance of Research
The genetic landscape of prostate cancer susceptibility in Africa is, like the continent itself, a picture of sweeping diversity, the largest study of the phenomenon concludes.
Video
Kidney Cancer Updates - GU Oncology Cancer Highlights: ESMO 2024
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the kidney cancer clinical updates you need to know from ESMO 2024.
Video
Bladder Cancer Updates - GU Oncology Cancer Highlights: ESMO 2024
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates you need to know from ESMO 2024.
Video
Prostate Cancer Updates - GU Oncology Cancer Highlights: ESMO 2024
The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from ESMO 2024.
News
Dana-Farber Research News 11.01.2024
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from October 1 through October 15.
News
Innovative Endometrial Cancer Research Offers Fresh Promise for Patients
For the past decade, new cases of endometrial (uterine) cancer have been on the rise in the United States. The past few years, however, have brought a more promising rise: A new generation of drugs and drug combinations that are improving the outlook for patients with the disease.
News
Dana-Farber Research News 10.15.2024
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from September 16 through September 30.